PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

Abstract

dertaken to better understand the factors influencing the funding decisions. RESULTS: During this period three submissions were considered under the RoR criteria, two in 2008 and one in 2009. None of these were approved for listing on the basis of the RoR, however two were accepted on the basis of high clinical need and high but acceptable cost-effectiveness ratio. No submission has requested consideration under the RoR, or been assessed under this criteria by the PBAC, since November 2009. In comparison, from 2008-2011, 4 new applications and 5 re-submissions requested listing on the LSDP and 3 of these were successful. CONCLUSIONS: Despite stricter criteria for the LSDP than the RoR, applications to the LSDP have had a better success rate. The RoR has not been used to justify a listing on the PBS for at least four years, perhaps indicating that these criteria are no longer favoured by the PBAC.